Skip to main content
LobbyMap

AstraZeneca

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
53/100
Moderate Influence
$19.4M
Total Lobby Spend
5
Policy Issues
8
Lobbyists
1
Revolving Door

AstraZeneca reported $19.4 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Health IssuesPharmacyMedical/Disease ResearchTaxationGovernment Issues

Government Entities Contacted

Food & Drug Administration
Dept of Health & Human Services
Dept of Treasury
US Trade Representative
US Senate
Dept of Homeland Security
Small Business Administration
Dept of Energy

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarSquire Patton Boggs LLP
MED
2$874K
2020 Apr-JunCassidy & Associates LLP
HCRPHAMED+1
4$1.0M
2020 Jul-SepAkin Gump LLP
PHATAX
3$1.2M
2020 Oct-DecAkin Gump LLP
TAXPHAHCR+1
4$1.1M
2021 Jan-MarK&L Gates LLP
HCR
4$1.1M
2021 Apr-JunSquire Patton Boggs LLP
PHAHCRGOV
1$894K
2021 Jul-SepHolland & Knight LLP
MEDPHAHCR+2
4$1.0M
2021 Oct-DecK&L Gates LLP
HCRGOVPHA
3$1.3M

AstraZeneca Lobbying FAQ

AstraZeneca has spent $19.4M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

AstraZeneca lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.

AstraZeneca has an Influence Score of 53/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

AstraZeneca employs 8 registered lobbyists, of whom 1 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

AstraZeneca has contacted 8 government entities as part of their lobbying activities, including Food & Drug Administration, Dept of Health & Human Services, Dept of Treasury.

Explore Other Lobbying Organizations

US Chamber of Commerce

$434.1M lobbying spend · Trade Association · Influence Score A

National Association of Realtors

$358.3M lobbying spend · Real Estate · Influence Score B

Pharmaceutical Research & Manufacturers of America

$141.9M lobbying spend · Pharmaceutical & Health Products · Influence Score B

Blue Cross Blue Shield Association

$130.1M lobbying spend · Insurance · Influence Score B

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.